Current status of treatment for 2019 novel coronavirus pneumonia / 中华微生物学和免疫学杂志

ABSTRACT

2019 novel coronavirus (2019-nCoV) is a new member of coronavirus family that can cause serious respiratory diseases after the emergence of severe acute respiratory syndrome-coronavirus ( SARS-CoV) and middle east respiratory syndrome-coronavirus ( MERS-CoV) . At present, there is no spe-cific antiviral drug targeting 2019-nCoV. In facing of the increasingly serious epidemic of 2019-nCoV pneu-monia and the urgent needs in drug treatment strategies, this paper reviewed the current research situation and progress in antiviral treatment for the newly identified disease.